文献速递慢性静脉疾病

私人保险公司静脉曲张政策不准确且不基于证据,需制定合理政策

Private payers' varicose vein policies are inaccurate, disparate, and not evidence based, which mandates a proposal for a reasonable and responsible policy for the treatment of venous disease.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-03-05

Varicose veins afflict more than one in five Americans, and although varicose veins may be an asymptomatic cosmetic concern in some, many others experience symptoms of pain, aching, heaviness, itching, and swelling.…

要点

  • 私人保险公司静脉曲张覆盖政策存在差异、错误和过时证据,未遵循循证指南。
  • 静脉疾病治疗可改善生活质量,需基于最佳证据制定合理覆盖政策。

核心结论

  • 私人保险公司静脉曲张政策不准确、差异大且不基于证据,需提出合理负责的治疗政策。

主要发现

  • 私人保险公司政策存在差异、自我服务、包含错误、使用过时证据且忽视循证指南。
  • 静脉疾病 adversely 影响生活质量,治疗可改善生活质量。

临床怎么用

  • 临床医生应认识到私人保险政策可能不准确且不基于证据,倡导基于最佳证据的合理政策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Varicose veins afflict more than one in five Americans, and although varicose veins may be an asymptomatic cosmetic concern in some, many others experience symptoms of pain, aching, heaviness, itching, and swelling. More advanced venous disease can result from untreated venous insufficiency. The complications of chronic venous disease, including bleeding, thrombosis, and ulceration, are seen in up to 2 million Americans annually. Numerous reports have documented venous disease adversely affects quality of life and that treatment of venous disease can improve quality of life. It has previously been documented that private insurers, and Centers for Medicare & Medicaid Services subcontractors for that matter, have disparate policies that in many instances are self-serving, contain mistakes, use outdated evidence, and disregard evidence-based guidelines. The two leading venous medical societies, the American Venous Forum and the American Venous and Lymphatic Society, have come together to review the varicose vein coverage policies of seven major U.S. private medical insurance carriers whose policies cover more than 150 million Americans. The authors reviewed the policies for venous disease and, if significant gaps or inconsistencies are found, we hope to point them out, and, finally, to propose a thoughtful and reasonable policy based on the best available evidence.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Welch HJ, Schul MW, Monahan DL, et al. Private payers' varicose vein policies are inaccurate, disparate, and not evidence based, which mandates a proposal for a reasonable and responsible policy for the treatment of venous disease. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33684590. doi:10.1016/j.jvsv.2020.12.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。